Loading...

NEXGEL, Inc.

NXGLNASDAQ
Healthcare
Medical - Instruments & Supplies
$0.61
$0.10(20.14%)
U.S. Market opens in 13h 45m

NEXGEL, Inc. Fundamental Analysis

NEXGEL, Inc. (NXGL) shows moderate financial fundamentals with a PE ratio of -1.61, profit margin of -28.54%, and ROE of -70.23%. The company generates $0.0B in annual revenue with strong year-over-year growth of 31.46%.

Key Strengths

PEG Ratio-0.13
Current Ratio1.70

Areas of Concern

ROE-70.23%
Operating Margin-31.37%
Cash Position4.13%
We analyze NXGL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -53.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-53.9/100

We analyze NXGL's fundamental strength across five key dimensions:

Efficiency Score

Weak

NXGL struggles to generate sufficient returns from assets.

ROA > 10%
-27.72%

Valuation Score

Excellent

NXGL trades at attractive valuation levels.

PE < 25
-1.61
PEG Ratio < 2
-0.13

Growth Score

Excellent

NXGL delivers strong and consistent growth momentum.

Revenue Growth > 5%
31.46%
EPS Growth > 10%
24.00%

Financial Health Score

Moderate

NXGL shows balanced financial health with some risks.

Debt/Equity < 1
1.05
Current Ratio > 1
1.70

Profitability Score

Weak

NXGL struggles to sustain strong margins.

ROE > 15%
-7023.48%
Net Margin ≥ 15%
-28.54%
Positive Free Cash Flow
No

Key Financial Metrics

Is NXGL Expensive or Cheap?

P/E Ratio

NXGL trades at -1.61 times earnings. This suggests potential undervaluation.

-1.61

PEG Ratio

When adjusting for growth, NXGL's PEG of -0.13 indicates potential undervaluation.

-0.13

Price to Book

The market values NEXGEL, Inc. at 1.30 times its book value. This may indicate undervaluation.

1.30

EV/EBITDA

Enterprise value stands at -0.62 times EBITDA. This is generally considered low.

-0.62

How Well Does NXGL Make Money?

Net Profit Margin

For every $100 in sales, NEXGEL, Inc. keeps $-28.54 as profit after all expenses.

-28.54%

Operating Margin

Core operations generate -31.37 in profit for every $100 in revenue, before interest and taxes.

-31.37%

ROE

Management delivers $-70.23 in profit for every $100 of shareholder equity.

-70.23%

ROA

NEXGEL, Inc. generates $-27.72 in profit for every $100 in assets, demonstrating efficient asset deployment.

-27.72%

Following the Money - Real Cash Generation

Operating Cash Flow

NEXGEL, Inc. generates limited operating cash flow of $-1.57M, signaling weaker underlying cash strength.

$-1.57M

Free Cash Flow

NEXGEL, Inc. generates weak or negative free cash flow of $-1.58M, restricting financial flexibility.

$-1.58M

FCF Per Share

Each share generates $-0.17 in free cash annually.

$-0.17

FCF Yield

NXGL converts -26.61% of its market value into free cash.

-26.61%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.61

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.13

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.30

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.51

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.70

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.70

vs 25 benchmark

ROA

Return on assets percentage

-0.28

vs 25 benchmark

ROCE

Return on capital employed

-0.43

vs 25 benchmark

How NXGL Stacks Against Its Sector Peers

MetricNXGL ValueSector AveragePerformance
P/E Ratio-1.6128.65 Better (Cheaper)
ROE-70.23%795.00% Weak
Net Margin-28.54%-49787.00% (disorted) Weak
Debt/Equity1.050.40 Weak (High Leverage)
Current Ratio1.703.73 Neutral
ROA-27.72%-20255.00% (disorted) Weak

NXGL outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews NEXGEL, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

1100.62%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

6.11%

Industry Style: Defensive, Growth, Innovation

Growing

FCF CAGR

48.42%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ